Stewart reported an algorithm that can be used evaluate a patient suspected of having primary aldosteronism. The author is from Queen Elizabeth Hospital in Birmingham, England.
Patient selection: hypertension with low plasma renin and normal to high plasma aldosterone levels
Initial evaluation: Postural study (supine for a period then upright) with measurement of plasma aldosterone and 11-beta-hydroxycorticosterone.
Differential diagnosis:
(1) bilateral adrenal hyperplasia (BAH)
(2) angiotensin-II-responsive aldosterone producing adenoma (ARAPA)
(3) aldosterone-producing tumor (APT)
(4) glucocorticoid-suppressible hyperaldosteronism (GSA)
Change in Aldosterone |
Change in 11-beta-OH-C |
Adrenal Mass |
Consider (from List Above) |
---|---|---|---|
rise |
normal |
none or equivocal |
1 (BAH) |
rise |
normal |
> 1 cm mass |
2 (ARAPA) |
no rise or fall |
elevated |
> 1 cm mass |
3 (APT) |
no rise or fall |
elevated |
none or equivocal |
4 (GSA) |
Glucocorticoid-suppressible hyperaldosteronism can be confirmed by:
(1) corticotropin stimulation test
(2) dexamethasone suppression test
(3) adrenal vein catheterization with blood sampling
Purpose: To evaluate a patient with clinical and biochemical findings suggestive of primary hyperaldosteronism using an algorithm by Stewart.
Specialty: Endocrinology, Clinical Laboratory
Objective: clinical diagnosis, including family history for genetics, criteria for diagnosis
ICD-10: E24,